🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271
The purpose of this study is to evaluate the safety of Sabin Inactivated Po...
Status
Completed
Location
Gaoan Center for Disease Control and Prevention
Start Date
2022-06-13
Trial ID
NCT05432141
Treatments Being Tested
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
The purpose of this cohort study is to determine vaccine-specific rates of ...
Status
Completed
Location
Multiple Locations
Start Date
2010-02-08
Trial ID
NCT01129362
Treatments Being Tested
The main objectives of the study are to demonstrate the non-inferiority of ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-12-17
Trial ID
NCT06494475
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09-26
Trial ID
NCT00369824
Treatments Being Tested
This study has been designed to support the indication of the candidate vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-17
Trial ID
NCT01345240
To monitor the occurrence of invasive Hib disease over time and to determin...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00855855
Treatments Being Tested
This study was designed to assess the lot comparability of DAPTACEL, as wel...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00662870
The objective for this study is to characterize the safety profile of PENTA...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00804284
Treatments Being Tested